| Dr Brendan Haigis, MD | |
|
1 Genesys Pkwy, Grand Blanc, MI 48439-8065 | |
| (810) 606-6372 | |
| Not Available |
| Full Name | Dr Brendan Haigis |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 11 Years |
| Location | 1 Genesys Pkwy, Grand Blanc, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043620362 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 4301104994 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ascension St Mary's Hospital | Saginaw, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cep America Llc | 6608056171 | 575 |
News Archive
Existing limited evidence suggests that wearing face coverings to protect against COVID-19 does not lead to a false sense of security and is unlikely to increase the risk of infection through wearers foregoing other behaviours such as good hand hygiene, say researchers from the University of Cambridge and King's College London.
Americans are watching with alarm as a new coronavirus spreads in China and cases pop up in the United States. They are barraged with information about what kinds of masks are best to prevent viral spread. Students are handing out masks in Seattle. Masks have run out in Brazos County, Texas.
In its recently released annual 2010 update, ChartTrends®: Biologics in Rheumatoid Arthritis, BioTrends Research Group, Inc. finds that newer biologic agents such as UCB's Cimzia and Centocor OrthoBiotech's Simponi, although lagging in overall market share, have begun to penetrate the first line biologic position primarily at the expense of Pfizer/Amgen's Enbrel and Abbott's Humira.
Researchers at the University of Chicago have found that a recently discovered biological process known as sumoylation - until now thought to be active only in the nucleus - also occurs near the cell's surface where it regulates at least one and possibly many kinds of proteins, providing a novel target for the development of new drugs.
The Academy of Medical Sciences is today (Friday, 13th October) announcing the pledge from The Yusuf and Farida Hamied Foundation1 for a scheme to build stronger research links between the UK and India to jointly address the challenge of antimicrobial resistance (AMR).
› Verified 6 days ago
| Entity Name | Degara App Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265976971 PECOS PAC ID: 7618251398 Enrollment ID: O20170223001941 |
News Archive
Existing limited evidence suggests that wearing face coverings to protect against COVID-19 does not lead to a false sense of security and is unlikely to increase the risk of infection through wearers foregoing other behaviours such as good hand hygiene, say researchers from the University of Cambridge and King's College London.
Americans are watching with alarm as a new coronavirus spreads in China and cases pop up in the United States. They are barraged with information about what kinds of masks are best to prevent viral spread. Students are handing out masks in Seattle. Masks have run out in Brazos County, Texas.
In its recently released annual 2010 update, ChartTrends®: Biologics in Rheumatoid Arthritis, BioTrends Research Group, Inc. finds that newer biologic agents such as UCB's Cimzia and Centocor OrthoBiotech's Simponi, although lagging in overall market share, have begun to penetrate the first line biologic position primarily at the expense of Pfizer/Amgen's Enbrel and Abbott's Humira.
Researchers at the University of Chicago have found that a recently discovered biological process known as sumoylation - until now thought to be active only in the nucleus - also occurs near the cell's surface where it regulates at least one and possibly many kinds of proteins, providing a novel target for the development of new drugs.
The Academy of Medical Sciences is today (Friday, 13th October) announcing the pledge from The Yusuf and Farida Hamied Foundation1 for a scheme to build stronger research links between the UK and India to jointly address the challenge of antimicrobial resistance (AMR).
› Verified 6 days ago
| Entity Name | Cep America Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912687328 PECOS PAC ID: 6608056171 Enrollment ID: O20230815000906 |
News Archive
Existing limited evidence suggests that wearing face coverings to protect against COVID-19 does not lead to a false sense of security and is unlikely to increase the risk of infection through wearers foregoing other behaviours such as good hand hygiene, say researchers from the University of Cambridge and King's College London.
Americans are watching with alarm as a new coronavirus spreads in China and cases pop up in the United States. They are barraged with information about what kinds of masks are best to prevent viral spread. Students are handing out masks in Seattle. Masks have run out in Brazos County, Texas.
In its recently released annual 2010 update, ChartTrends®: Biologics in Rheumatoid Arthritis, BioTrends Research Group, Inc. finds that newer biologic agents such as UCB's Cimzia and Centocor OrthoBiotech's Simponi, although lagging in overall market share, have begun to penetrate the first line biologic position primarily at the expense of Pfizer/Amgen's Enbrel and Abbott's Humira.
Researchers at the University of Chicago have found that a recently discovered biological process known as sumoylation - until now thought to be active only in the nucleus - also occurs near the cell's surface where it regulates at least one and possibly many kinds of proteins, providing a novel target for the development of new drugs.
The Academy of Medical Sciences is today (Friday, 13th October) announcing the pledge from The Yusuf and Farida Hamied Foundation1 for a scheme to build stronger research links between the UK and India to jointly address the challenge of antimicrobial resistance (AMR).
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Brendan Haigis, MD 6 Watersedge Dr, Hudson, NH 03051-4545 Ph: () - | Dr Brendan Haigis, MD 1 Genesys Pkwy, Grand Blanc, MI 48439-8065 Ph: (810) 606-6372 |
News Archive
Existing limited evidence suggests that wearing face coverings to protect against COVID-19 does not lead to a false sense of security and is unlikely to increase the risk of infection through wearers foregoing other behaviours such as good hand hygiene, say researchers from the University of Cambridge and King's College London.
Americans are watching with alarm as a new coronavirus spreads in China and cases pop up in the United States. They are barraged with information about what kinds of masks are best to prevent viral spread. Students are handing out masks in Seattle. Masks have run out in Brazos County, Texas.
In its recently released annual 2010 update, ChartTrends®: Biologics in Rheumatoid Arthritis, BioTrends Research Group, Inc. finds that newer biologic agents such as UCB's Cimzia and Centocor OrthoBiotech's Simponi, although lagging in overall market share, have begun to penetrate the first line biologic position primarily at the expense of Pfizer/Amgen's Enbrel and Abbott's Humira.
Researchers at the University of Chicago have found that a recently discovered biological process known as sumoylation - until now thought to be active only in the nucleus - also occurs near the cell's surface where it regulates at least one and possibly many kinds of proteins, providing a novel target for the development of new drugs.
The Academy of Medical Sciences is today (Friday, 13th October) announcing the pledge from The Yusuf and Farida Hamied Foundation1 for a scheme to build stronger research links between the UK and India to jointly address the challenge of antimicrobial resistance (AMR).
› Verified 6 days ago
Dr. Tara Knisely, MD, MPH Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1 Genesys Pkwy, Grand Blanc, MI 48439 Phone: 810-606-5000 | |
Alison Marie Ralston, Emergency Medicine Medicare: May Accept Medicare Assignments Practice Location: 1 Genesys Pkwy, Grand Blanc, MI 48439 Phone: 810-606-6372 | |
Brian T West, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1 Genesys Pkwy, Grand Blanc, MI 48439 Phone: 810-606-6137 | |
Roland R Tindle, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 8401 Holly Rd, Grand Blanc, MI 48439 Phone: 810-695-8011 Fax: 810-695-8002 | |
Dr. Ryan Patrick Kirby, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1 Genesys Pkwy, Grand Blanc, MI 48439 Phone: 810-606-5000 | |
Dr. John Nicholas Vitali, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Genesys Parkway, Grand Blanc, MI 48439 Phone: 810-606-5000 |